Sensei biotherapeutics inc.

Major-Pharmaceuticals

SNSE


Executive/
Director

Price

  • Last Close
  • $ 0.51
    $ +0.01 2.02 %
    Jan 3, 2025
  • 52-Week High/Low
  • $1.17 - $0.53
  • YTD
  • 3.3%

  • Trading Volume
  • 552
  • Market Cap Full
  • $ 12.7M
  • Shares Outstanding
  • 25M
    Nov 2, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - - - -60.2% 0.7% 53.2% 3.3%
Q2 - - - - - -32.8% -1.7% -24% -41.6% -
Q3 - - - - - 7.8% -31.7% -34.2% -13.6% -
Q4 - - - - - -44.9% -3.9% -7.7% 6.3% -
J F M A M J J A S O N D
2025 3.3% - - - - - - - - - - -
2024 18.5% 3.7% 24.7% -10.9% -19.4% -15% 1.9% -13.6% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%0%-74%-54%-29%3%

Earnings

2021 2022 2023
Q1 -0.42 -0.4 -0.33
Q2 -0.32 -0.34 -0.31
Q3 -0.32 -0.44 -0.28
Q4 -0.27 -0.40 -
A -1.3 -1.6 -0.92

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 30.7 31
Jun 30.6 30.6 31
Sep 30.6 30.7 26.6
Dec 30.6 30.7 25

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - 0.1 - -
Debt – Equity Ratio - - - - -
Interest Coverage 50 - -19 -2.4 -
Equity multiplier - - - - -